Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ed Schuuring"'
Autor:
Paul van derLeest, Birgitta Hiddinga, Anneke Miedema, Maria L. Aguirre Azpurua, Naomi Rifaela, Arja terElst, Wim Timens, Harry J. M. Groen, Léon C. vanKempen, T. Jeroen N. Hiltermann, Ed Schuuring
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2910-2922 (2021)
Immunotherapy for metastasized non‐small‐cell lung cancer (NSCLC) can show long‐lasting clinical responses. Selection of patients based on programmed death‐ligand 1 (PD‐L1) expression shows limited predictive value for durable clinical bene
Externí odkaz:
https://doaj.org/article/3d6ef98ec808424e9bf8c4b94e7a4fc2
Autor:
Paul van derLeest, Ed Schuuring
Publikováno v:
Molecular Oncology, Vol 14, Iss 3, Pp 487-489 (2020)
Externí odkaz:
https://doaj.org/article/f6d923ab256b43ddb8f8fe2545443678
Autor:
Naomi Rifaela, T. Jeroen N. Hiltermann, Birgitta I. Hiddinga, Harry J.M. Groen, Léon C van Kempen, Ed Schuuring, Wim Timens, Arja ter Elst, Paul van der Leest, Anneke Miedema, Maria L Aguirre Azpurua
Publikováno v:
Molecular Oncology
Molecular oncology, 15(11), 2910-2922. Wiley
Molecular oncology, 15(11), 2910-2922. Wiley
Immunotherapy for metastasized non‐small‐cell lung cancer (NSCLC) can show long‐lasting clinical responses. Selection of patients based on programmed death‐ligand 1 (PD‐L1) expression shows limited predictive value for durable clinical bene